Fiche du document
2012
- doi: 10.1186/1752-1947-6-416
- issn: 1752-1947
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1186/1752-1947-6-416
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/23231992
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1752-1947
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_D276AA4924B00
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Sujets proches
Maxillary antrum Highmore's antrum Antrum of Highmore Sinus maxillaris Carcinoma Cancers Malignancy (Cancer) Malignant tumorsCiter ce document
D. Mohammed et al., « Lymphoepithelial carcinoma in the maxillary sinus: a case report. », Serveur académique Lausannois, ID : 10.1186/1752-1947-6-416
Métriques
Partage / Export
Résumé
INTRODUCTION: Lymphoepithelial carcinoma of the maxillary sinus is a very rare malignancy and it can be difficult to make a pre-operative diagnosis. CASE PRESENTATION: A 72-year-old Caucasian woman presented to our facility with an isolated right-side epistaxis that had been present for three months, with the results of a computed tomography scan showing a soft tissue mass in the right maxillary sinus with an impacted tooth. The results of a transnasal endoscopic biopsy were compatible with a lymphoepithelial carcinoma, following which our patient underwent a radical excision of the mass. The final histology results revealed lymphoepithelial carcinoma of the maxillary sinus with negative assays for Epstein-Barr virus. Our patient was given post-operative external radiotherapy and has remained disease-free at three-year follow-up. CONCLUSIONS: This report details the diagnosis and management of a case of lymphoepithelial carcinoma of the maxillary sinus, which is a very rare malignant tumor with very little mention in the literature. Only a strong suspicion with systematic use of various patho-immunological tests helps to arrive at a definitive diagnosis by excluding other better-known tumors.